WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2014

Nov 17, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2014-11-13

Reporting Person: GAILEY JOHN R (Sr. VP, Gen. Counsel & Sec.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-11-13	Common Stock	M	20000.0000	$21.3400	Acquired	87891.3716	Direct
2014-11-13	Common Stock	S	8000.0000	$52.4100	Disposed	79891.3716	Direct
2014-11-13	Common Stock	S	20000.0000	$52.3603	Disposed	59891.3716	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-11-13	Stock Option (Right to Buy)	$21.3400	M	20000.0000	Disposed	2020-03-22	Common Stock (20000.0000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1463.3700	Indirect
Common Stock	11222.1400	Indirect

Footnotes

F1: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.